Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) Cost of Revenue (2020 - 2025)

Trulieve Cannabis (TCNNF) has 6 years of Cost of Revenue data on record, last reported at $118.0 million in Q4 2025.

  • For Q4 2025, Cost of Revenue fell 57.82% year-over-year to $118.0 million; the TTM value through Dec 2025 reached $470.0 million, down 26.14%, while the annual FY2025 figure was $470.0 million, 0.16% changed from the prior year.
  • Cost of Revenue reached $118.0 million in Q4 2025 per TCNNF's latest filing, roughly flat from $118.3 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $285.6 million in Q3 2023 and bottomed at $44.6 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $119.4 million, with a median of $116.3 million recorded in 2025.
  • Peak YoY movement for Cost of Revenue: skyrocketed 381.61% in 2022, then crashed 61.14% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $50.6 million in 2021, then surged by 381.61% to $243.8 million in 2022, then tumbled by 45.4% to $133.1 million in 2023, then surged by 110.13% to $279.7 million in 2024, then crashed by 57.82% to $118.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $118.0 million in Q4 2025, $118.3 million in Q3 2025, and $119.2 million in Q2 2025.